MD Anderson ranked #1 in the nation for cancer care
The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s inception in 1990.
“At MD Anderson, we remain singularly focused on eliminating cancer,” said Peter WT Pisters, M.D., president of MD Anderson. “We are pleased...
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class TCR NK cell therapy for multiple myeloma
The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe...
New single-cell study provides novel insights into gastric cancer
A new study led by researchers at The University of Texas MD Anderson Cancer Center provides a deeper understanding of the evolution of the tumor microenvironment during gastric cancer progression. Highlights of the study, published today in Cancer Cell, include a link between multicellular communities and clinical outcomes as well as a potential new therapeutic target.
Gastric adenocarcinoma is one of the most lethal cancers worldwide...
